- AdventHealth Research Institute
Alzheimer’s disease is often thought of as a disease of aging, but scientists are increasingly recognizing that biology also plays an important role. For women, the risk appears to be significantly higher. To better understand what researchers are learning, we asked Lauren Oberlin, PhD, an investigator at the AdventHealth Research Institute, to answer some of the most important questions about women and brain health.
Many people do not realize that Alzheimer’s disease affects women differently than men. What do we know about that today?
Dr. Oberlin:
One of the most striking facts about Alzheimer’s disease is that women are disproportionately affected. In the United States, nearly two thirds of people living with Alzheimer’s are women. That means roughly twice as many women as men are living with the disease. For researchers, that statistic raises an important question. Why are women at greater risk?
For years people assumed the explanation was simple because women live longer. Is that still the thinking?
Dr. Oberlin:
That was the common explanation for a long time, but research now shows that lifespan alone does not explain the difference. Women do tend to live longer on average, but longevity accounts for only part of the increased risk. Scientists now believe other biological factors are involved, including differences in hormones, immune function, and genetics that may influence how Alzheimer’s disease develops.
Why has it taken so long for researchers to focus on these differences between men and women?
Dr. Oberlin:
Historically, biomedical research did not consistently examine sex differences when studying disease. A widely cited paper published in Alzheimer’s and Dementia highlighted this gap and called attention to how poorly sex specific factors had been integrated into Alzheimer’s research. That lack of focus has limited our understanding of the disease and may have slowed progress in developing effective treatments.
What kinds of biological differences are scientists now investigating?
Dr. Oberlin:
Researchers are exploring several possible mechanisms. Hormonal changes, particularly those that occur during menopause, may influence brain health and Alzheimer’s risk. Scientists are also studying how the immune system behaves differently in women and how certain genes associated with Alzheimer’s disease may affect women and men in different ways. These factors likely interact in complex ways that we are only beginning to understand.
Scientists are starting to uncover clues about what may drive this difference in risk. What are some of the most interesting discoveries emerging from research right now?
Dr. Oberlin:
One exciting area of research is identifying biological mechanisms that may contribute to the higher risk we see in women. Scientists are beginning to find evidence that certain pathways in the brain and immune system may function differently in women compared with men. When researchers can identify these mechanisms, it helps us better understand how the disease develops and where new opportunities for prevention or treatment may exist.
Why is understanding the reason behind this difference so important for treatment?
Dr. Oberlin:
Alzheimer’s disease is complex, and treatments that work for one group of people may not work the same way for another. If researchers can identify the biological pathways that increase risk in women, it may allow us to develop therapies that are more precise and more effective. Understanding these mechanisms is a critical step toward more personalized approaches to brain health.
What should women take away from this research right now?
Dr. Oberlin:
One of the most important messages is that brain health is closely connected to overall health. Factors such as cardiovascular health, metabolic health, sleep, physical activity, and cognitive engagement all influence how the brain ages. While scientists continue to study the biology behind Alzheimer’s risk, there are already many steps women can take to support brain health throughout their lives.
How is the AdventHealth Research Institute contributing to this work?
Dr. Oberlin:
Researchers at the AdventHealth Research Institute are working to better understand how biological, metabolic, and lifestyle factors influence brain health across the lifespan. By studying these connections, the goal is to identify new opportunities for earlier detection, prevention, and more personalized care for conditions like Alzheimer’s disease.
Lauren E. Oberlin, PhD is a researcher at the AdventHealth Research Institute studying how metabolism, hormones, and aging influence brain health in women.
Recent News
Alcohol, Marijuana and Type 1 Diabetes:
Whether it's a backyard barbecue, a football game or dinner with friends, alcohol and marijuana are common parts of social life. For people with Type 1 diabetes (T1D), understanding how they affect...
GLP-1 Medications: The Next Chapter in Diabetes Care
Ozempic®. Wegovy®. Zepbound®. Just a few years ago, most people had never heard these names. Today, they're among the most talked-about medications in the world. While much of the public conversation...
Q&A: Alcohol, Marijuana and Type 1 Diabetes
A Conversation with Daria Igudesman, PhD, RD, Postdoctoral Research Fellow, AdventHealth Translational Research Institute.
The Science That Moves Medicine Forward:
Have you ever wondered how breakthrough medicines are developed, how doctors determine the most effective treatments, or how healthcare continues to advance? The answer lies in clinical research—the...
Meet Jawanda Thacker: Helping Connect Today's Volunteers to Tomorrow's Medical Breakthroughs
Meet Jawanda Thacker: Helping Connect Today's Volunteers to Tomorrow's Medical Breakthroughs
Six Breakthroughs Shaping the Future of Diabetes Care
Several members of the AdventHealth Translational Research Institute (TRI) team traveled to New Orleans in June to attend the American Diabetes Association's (ADA) 2026 Scientific Sessions, where more...
AHRI Investigator Receives Prestigious American Diabetes Association Junior Faculty Development Award
The AdventHealth Translational Research Institute (TRI) is proud to announce that Dr. Justine Mucinski has received an American Diabetes Association (ADA) Junior Faculty Development Award.
Dr. Richard Pratley Featured in Nature Medicine for Breakthrough Obesity Research
Dr. Richard E. Pratley, senior investigator at the AdventHealth Translational Research Institute, has been featured as the corresponding author of a newly published study in Nature Medicine, one of...
Dr. Sparks Participates in LIMNA’s 17th Annual Metabolism and Aging Symposium
AdventHealth researcher Dr. Lauren Sparks recently had the honor of participating in LIMNA’s 17th Annual Symposium on “Metabolism and Aging” at the Olympic Museum in Lausanne
Advancing Cancer Research Closer to Home
At AdventHealth, we believe research is not separate from care. We believe the advancements made are what allow us to help our patients feel whole. That commitment is reflected in a new collaboration...
AdventHealth Research Institute Researchers to Present at American Diabetes Association Scientific Sessions
AdventHealth Research Institute (AHRI) is proud to have a strong presence at the American Diabetes Association (ADA) 2026 Scientific Sessions, with multiple investigators and research team members...
Moving More, Managing Better
For people living with type 1 diabetes, managing blood sugar is rarely simple. It’s a daily balancing act involving insulin, food, physical activity, technology and a constant stream of decisions.